<?xml version="1.0" encoding="UTF-8"?>
<ack id="jia225610-sec-0020">
 <title>Acknowledgements</title>
 <p>The members of the MaxART Consortium included the Eswatini Ministry of Health, Aidsfonds, Clinton Health Access Initiative (CHAI), the Eswatini National Network of People Living with HIV/AIDS (SWANNEPHA), the Southern African AIDS Information Dissemination Service (SAfAIDS), the South African Centre for Epidemiological Modelling and Analysis (SACEMA) and University of Amsterdam (UvA).</p>
 <sec id="jia225610-sec-0021">
  <title>Funding</title>
  <p>This trial was funded by the Dutch Postcode Lottery in the Netherlands, and the Embassy of the Kingdom of the Netherlands in Mozambique, and supported by Mylan Laboratories Limited, which provided the antiretroviral drugs; Médecins Sans Frontières (with funding from UNITAID) for VL testing; and British Columbia Centre for Excellence in HIV/AIDS for genotype testing. The MaxART Consortium thanks the many health workers and community members who actively participated in the MaxART study implementation. TB was supported by the Alexander von Humboldt Foundation through the Alexander von Humboldt Professor award, funded by the Federal Ministry of Education and Research; the Wellcome Trust; the European Commission; the Clinton Health Access Initiative; and from NICHD of NIH (R01‐HD084233), NIA of NIH (P01‐AG041710), NIAID of NIH (R01‐AI124389 and R01‐AI112339) as well as FIC of NIH (D43‐TW009775). DS was supported, in part, by NIH R01AI112339.</p>
 </sec>
</ack>
